newsfilter
← Latest News
Business Wire·

DiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer

Executive with Strong Track Record in Advancing Pipelines Through Clinical Development DiaMedica Therapeutics Inc. (NASDAQ:DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for